GGrantIndex
Sort

130,381 grants matching hiv

Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine

$4,294,474
Kimberly Wallace · Niaid Extramural Activities · Z01 · FY2007 · AI

PS04-012, HIV PREVENTION PROJECTS

$4,292,744
Ralph Wilmoth · Colorado State Dept/Pub Hlth & Environmt · U62 · FY2009 · PS

TARGET: INCREASING ACCESS TO HIV COUNSELING, TESTING & ENHANCING HIV/AIDS PREVENT

$4,288,323
Dawn Dixon · Population Services International · U2G · FY2016 · GH

The RCMI Program in Health Disparities Research at Meharry Medical College

$4,286,390
Maria F Lima · Meharry Medical College · U54 · FY2017 · MD

University of Pittsburgh Multicenter AIDS Cohort Study (MACS)

$4,283,706
Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AI

General Clinical Research Center

$4,278,623
University Of California San Francisco · M01 · FY2004 · RR

The Center for HIV RNA Studies (CRNA)

$4,278,491
Alice Telesnitsky · University Of Michigan At Ann Arbor · P50 · FY2014 · GM

Harvard University Center for AIDS Research

$4,278,137
Bruce D Walker · Harvard Medical School · P30 · FY2014 · AI

North American AIDS Cohorts on Collaboration and Design (NAACCORD)

$4,277,114
Richard Douglas Moore · Johns Hopkins University · U01 · FY2021 · AI

Center for AIDS Research

$4,276,269
David Mitchell Smith · University Of California, San Diego · P30 · FY2019 · AI

PS09-962 SUPPORTING THE IMPLEMEN & EXPANSION OF HIGH QUAL HIV PREVENTION, CARE

$4,275,625
David Hoos · Columbia University Health Sciences · U2G · FY2012 · PS

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$4,271,713
Patrick Chaulk · Baltimore City Health Department · U62 · FY2013 · PS

COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$4,265,225
Amy Kile-Puente · California Department Of Public Health · U62 · FY2016 · PS

Targeting Neutralizing Epitopes in the HIV Envelope

$4,260,986
Susan W Barnett · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2009 · AI

Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ

$4,260,726
Georgia D Tomaras · Duke University · P01 · FY2022 · AI

Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine

$4,255,134
Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2008 · AI

Global innate immune responses to HIV-1 infection

$4,254,392
John A T Young · Salk Institute For Biological Studies · P01 · FY2010 · AI

UCSF-Gladstone Center for AIDS Research

$4,254,133
Monica Gandhi · University Of California, San Francisco · P30 · FY2019 · AI

The Center for HIV RNA Studies (CRNA)

$4,254,118
Alice Telesnitsky · University Of Michigan At Ann Arbor · P50 · FY2015 · GM

Development of rationally designed HIV vaccines

$4,253,554
Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Biodefense/Emerging Infection Vaccine Studies

$4,251,944
Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Biodefense/Emerging Infection Vaccine Studies

$4,251,944
Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health

$4,251,842
Sally Lynn Hodder · West Virginia University · U54 · FY2022 · GM

NIAID Specimen Repository

$4,251,684
Deborah Phippard · Precision Bioservices, Inc. · N01 · FY2025 · AI

Scientific Leadership Group Core

$4,251,464
Lisa B Hightow-Weidman · Florida State University · UM2 · FY2023 · HD